Back to Search
NICHOLAS CURTIN, PHARMD
PHARMD
Pharmacist
NPI: 1689668899Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
13235(OK)
Research & Publications (20)
Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility.
PMID 15938729·Clin Lab Haematol·2005
5-case
Effects of UCP3 genotype, temperature and muscle type on energy turnover of resting mouse skeletal muscle.
PMID 18648851·Pflugers Arch·2009
7-preclinical
Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma.
PMID 19174487·Clin Cancer Res·2009
7-preclinical
Preclinical evaluation of a novel pyrimidopyrimidine for the prevention of nucleoside and nucleobase reversal of antifolate cytotoxicity.
PMID 19509274·Mol Cancer Ther·2009
7-preclinical
Temperature change as a probe of muscle crossbridge kinetics: a review and discussion.
PMID 19364742·Proc Biol Sci·2009
6-review
Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide.
PMID 19159673·Brain Behav Immun·2009
7-preclinical
Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines.
PMID 19568233·Br J Cancer·2009
8-other
Psychological stress suppresses innate IFN-gamma production via glucocorticoid receptor activation: reversal by the anxiolytic chlordiazepoxide.
PMID 19217938·Brain Behav Immun·2009
7-preclinical
Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle.
PMID 19405813·Rejuvenation Res·2009
7-preclinical
Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration.
PMID 19046481·Int J Neuropsychopharmacol·2009
4-observational
Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines.
PMID 19174557·Mol Cancer Ther·2009
7-preclinical
Transient treatment with CDK inhibitors eliminates proliferative potential even when their abilities to evoke apoptosis and DNA damage are blocked.
PMID 19066469·Cell Cycle·2008
8-other
Exploiting the Achilles heel of cancer: the therapeutic potential of poly(ADP-ribose) polymerase inhibitors in BRCA2-defective cancer.
PMID 18820000·Br J Radiol·2008
7-preclinical
The energetic cost of activation in mouse fast-twitch muscle is the same whether measured using reduced filament overlap or N-benzyl-p-toluenesulphonamide.
PMID 18373742·Acta Physiol (Oxf)·2008
7-preclinical
Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.
PMID 19047122·Clin Cancer Res·2008
3-trial
8-Biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK).
PMID 18678488·Bioorg Med Chem Lett·2008
4-observational
A comparative study of genome-wide SNP, CGH microarray and protein expression analysis to explore genotypic and phenotypic mechanisms of acquired antiestrogen resistance in breast cancer.
PMID 17899364·Breast Cancer Res Treat·2008
4-observational
PARP inhibitor development for systemic cancer targeting.
PMID 17896912·Anticancer Agents Med Chem·2007
6-review
Energy turnover for Ca2+ cycling in skeletal muscle.
PMID 17882515·J Muscle Res Cell Motil·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1055 W 121ST ST S STE 101
JENKS, OK 74037 - Phone
- (918) 528-6000
Quick Facts
- NPI
- 1689668899
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile